5.91
price down icon3.90%   -0.24
after-market 시간 외 거래: 29.72 23.81 +402.88%
loading

Relmada Therapeutics Inc (RLMD) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
1.04%
10.33
10.22 18.22 19.08 23.01
Operating Income/Loss
1.04%
-10.33
-10.22 -18.22 -19.08 -23.01
Nonoperating Income/Loss
33.54%
0.2359
0.3549 0.659 0.4184 1.2829
Income/Loss From Continuing Operations Before Tax
2.28%
-10.09
-9.8664 -17.56 -18.66 -21.73
Income/Loss From Continuing Operations After Tax
2.28%
-10.09
-9.8664 -17.56 -18.66 -21.73
Net Income/Loss
2.28%
-10.09
-9.8664 -17.56 -18.66 -21.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
33.19
33.19 30.41 0.00351 30.17
Diluted Average Shares
0.00%
33.19
33.19 30.41 0.00351 30.17
Basic Earnings Per Share
0.00%
-0.30
-0.30 -0.58 -0.62 -0.72
Diluted Earnings Per Share
0.00%
-0.30
-0.30 -0.58 -0.62 -0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
자본화:     |  볼륨(24시간):